rubidium has been researched along with regadenoson in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bateman, TM; Case, JA; Courter, SA; Cullom, SJ; McGhie, AI | 1 |
| Caobelli, F; Clerc, OF; Frey, SM; Haaf, P; Honegger, U; Zellweger, MJ | 1 |
2 other study(ies) available for rubidium and regadenoson
| Article | Year |
|---|---|
Regadenoson pharmacologic rubidium-82 PET: a comparison of quantitative perfusion and function to dipyridamole.
Topics: Aged; Blood Pressure; Body Mass Index; Chlorides; Dipyridamole; Exercise Test; Female; Hemodynamics; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Perfusion Imaging; Perfusion; Positron-Emission Tomography; Purines; Pyrazoles; Radiopharmaceuticals; Rubidium; Rubidium Radioisotopes; Ventricular Function, Left | 2013 |
Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET.
Topics: Adenosine; Coronary Artery Disease; Coronary Circulation; Hemodynamics; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Rubidium; Stroke Volume; Vasodilator Agents; Ventricular Function, Left | 2022 |